Xconomy Forum: Pharma’s Bet on Boston Innovation

November 4, 2009 – Agenda
1:15 – 2:00
Registration
2:00 – 2:05Welcome and Opening Remarks
Bob Buderi, Founder and Editor in Chief, Xconomy
Michelle Dipp, Head of US CEEDD, GlaxoSmithKline
2:05 – 2:35Keynote: Biotech and Innovation in Boston
Christoph Westphal, CEO, Sirtris; SVP, Centre of Excellence for External Drug Discovery, GlaxoSmithKline
2:35 – 2:50Innovation Profile: Aileron Therapeutics
Joseph Yanchik III,
 President and CEO
2:50 – 3:40Pharma Ventures
Jean George, General Partner, Advanced Technology Ventures (moderator)
Russell Herndon, President and CEO, Hydra Biosciences
Maggie Flanagan LeFlore, Managing Director, MedImmune Ventures
Campbell Murray, Managing Director, Novartis Venture Funds
Daphne Zohar, Founder and Managing Partner, PureTech Ventures
3:40 – 4:00Networking Break
4:00 – 4:15Innovation Profile: Aveo Pharmaceuticals
Tuan Ha-Ngoc, President and CEO
4:15 – 4:30Innovation Profile: Enlight Biosciences
David Steinberg, Founding CEO
4:30 – 4:45Innovation Profile: Merck’s Acquisition of GlycoFi
Natarajan Sethuraman, Senior Director, Merck GlycoFi
4:45 – 5:30Closing Address and Chat
Deborah Dunsire, CEO, Millennium: The Takeda Oncology Company
Interviewed by Noubar Afeyan, Co-founder, Managing Partner and CEO, Flagship Ventures
5:30 – 7:00
Networking Reception
CLICK HERE FOR MORE DETAILS AND TO REGISTER.